Please ensure Javascript is enabled for purposes of website accessibility

Will the Pandemic Cause Smokers to Switch to Snus or Nicotine Pouches?

By Rich Duprey - Updated Apr 14, 2020 at 10:24AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

There are several good reasons consumers would be motivated to change their habits.

Tobacco is often viewed as a recession-resistant segment of the market because no matter how bad things get, smokers will typically continue smoking -- perhaps even more so. Yet because COVID-19, the disease caused by the novel coronavirus, has been found to strike smokers harder than the rest of the population, many may begin rethinking their habit in earnest. 

With Altria under fire for its investment in the much-criticized Juul Labs electronic cigarette and British American Tobacco suing Philip Morris International for patent infringement over its IQOS heat-not-burn tobacco device, snus and nicotine pouches may become the means by which smokers finally break away from cigarettes.

Zyn nicotine pouches

ZYN nicotine patches. Image source: Swedish Match.

The move away from cigarettes ...

Snus is a moist powdered tobacco typically sold in small pouches that are stuck between the lip and gum. It was already among the fastest-growing tobacco products on the market. Sales in 2018 surged 250%, and Nielsen says it's becoming a $400 million business, accounting for 4.5% of all tobacco sales this year.

While British American Tobacco is the snus industry leader with its Camel brand, Swedish Match last year became the first company to earn a reduced-risk label from the Food and Drug Administration when eight of its General brand of snus were approved for the designation.

That should give it a big competitive advantage, but as the industry continues to evolve, it may be nicotine pouches that prove to be the real category killer.

... And then from tobacco

Tobacco-free and lozenge-size, nicotine pouches are quickly gaining traction with users. Swedish Match rolled out the ZYN brand nationally last year and has attracted an 87% share of the market. 

It was the big splash made by Swedish Match that helped push Altria to acquire the international business of Burger Sohne for its on! brand of nicotine pouches. So worried was Altria about being left behind that it made sure it was able to start selling the pouches even before the deal closed.

British American is also investing heavily in nicotine pouches. Last year it narrowed its potentially reduced-risk product portfolio to three brands: Vuse, for vapor products; glo, for heated tobacco; and Velo, for nicotine pouches (or what it calls modern oral products).

It may be coincidental to the pandemic landing here, but there has also been an increase in television advertising surrounding the Velo brand, although the tobacco giant did announce last summer it would be expanding its introduction of the brand.

As consumers self-isolate, precautions to prevent upper respiratory illness as a gateway for COVID-19 infection are rising. Smoking indoors increases risks not only to smokers, but also to those around them through secondhand smoke.

Moreover, e-cigs awoke consumers to the fact there are alternatives to tobacco for nicotine consumption, and these nicotine pouches could be the clear winner since they are arguably even safer than snus because they're tobacco-free.

The big opportunity

Yet there are risks. In the assault on teen use of e-cigs, flavored tobacco products came under fire. Federal, state, and local regulators and politicians began banning their manufacture and sale. But some states are going further than others.

California is proposing to ban every flavored tobacco product, regardless of whether it is derived from tobacco or nicotine. Also, no matter how a person consumes them, they would be illegal. That would virtually wipe out the nicotine pouch market as ZYN and Velo only offer citrus and mint flavors, though the latter also makes a potentially permissible unflavored version .

Yet as many smokers consider the enhanced risks to them during the pandemic, there is a good chance nicotine pouches will become the preferred alternative to cigarettes.



Rich Duprey owns shares of Altria Group. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

British American Tobacco p.l.c. Stock Quote
British American Tobacco p.l.c.
BTI
$41.38 (1.50%) $0.61
Altria Group, Inc. Stock Quote
Altria Group, Inc.
MO
$45.74 (1.02%) $0.46
Philip Morris International Inc. Stock Quote
Philip Morris International Inc.
PM
$101.72 (0.71%) $0.72
Nielsen Holdings plc Stock Quote
Nielsen Holdings plc
NLSN
$27.52 (0.07%) $0.02
Swedish Match AB (publ) Stock Quote
Swedish Match AB (publ)
SWMAF
$10.10 (-2.88%) $0.30

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
403%
 
S&P 500 Returns
128%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 08/17/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.